Screener
NeoGenomics NEO Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | (unaudited)June 30, 2026 | December 31, 2025 |
|---|---|---|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $20,953 | $23,090 |
| Accrued compensation | 56,265 | 47,580 |
| Accrued expenses and other liabilities | 23,045 | 11,975 |
| Current portion of operating lease liabilities | 3,722 | 4,776 |
| Current portion of finance lease liabilities | 1,704 | 28 |
| Contract liabilities | 194 | 851 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's accrued expenses?
- NeoGenomics (NEO) reported accrued expenses of $56.27M in Q2 2026.
- How has NeoGenomics's accrued expenses changed year-over-year?
- NeoGenomics's accrued expenses increased by 15.9% year-over-year, from $48.56M to $56.27M.
- What is the long-term trend for NeoGenomics's accrued expenses?
- Over 5 years (2020 to 2025), NeoGenomics's accrued expenses has grown at a 14.0% compound annual growth rate (CAGR), from $24.73M to $47.58M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about NeoGenomics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude